249 related articles for article (PubMed ID: 27283929)
1. Effects of hemin on heme oxygenase-1, gastric emptying, and symptoms in diabetic gastroparesis.
Bharucha AE; Daley SL; Low PA; Gibbons SJ; Choi KM; Camilleri M; Saw JJ; Farrugia G; Zinsmeister AR
Neurogastroenterol Motil; 2016 Nov; 28(11):1731-1740. PubMed ID: 27283929
[TBL] [Abstract][Full Text] [Related]
2. CD206-positive M2 macrophages that express heme oxygenase-1 protect against diabetic gastroparesis in mice.
Choi KM; Kashyap PC; Dutta N; Stoltz GJ; Ordog T; Shea Donohue T; Bauer AJ; Linden DR; Szurszewski JH; Gibbons SJ; Farrugia G
Gastroenterology; 2010 Jun; 138(7):2399-409, 2409.e1. PubMed ID: 20178793
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus-9 reverses delayed gastric emptying of solids in diabetic mice.
Li X; Ji S; Cipriani G; Hillestad ML; Eisenman ST; Barry MA; Nath KA; Linden DR; Wright A; AlAsfoor S; Grover M; Sha L; Hsi LC; Farrugia G
Neurogastroenterol Motil; 2023 Nov; 35(11):e14669. PubMed ID: 37702100
[TBL] [Abstract][Full Text] [Related]
4. Carbon monoxide reverses diabetic gastroparesis in NOD mice.
Kashyap PC; Choi KM; Dutta N; Linden DR; Szurszewski JH; Gibbons SJ; Farrugia G
Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G1013-9. PubMed ID: 20378827
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.
Camilleri M; McCallum RW; Tack J; Spence SC; Gottesdiener K; Fiedorek FT
Gastroenterology; 2017 Nov; 153(5):1240-1250.e2. PubMed ID: 28760384
[TBL] [Abstract][Full Text] [Related]
6. Heme oxygenase-1 protects interstitial cells of Cajal from oxidative stress and reverses diabetic gastroparesis.
Choi KM; Gibbons SJ; Nguyen TV; Stoltz GJ; Lurken MS; Ordog T; Szurszewski JH; Farrugia G
Gastroenterology; 2008 Dec; 135(6):2055-64, 2064.e1-2. PubMed ID: 18926825
[TBL] [Abstract][Full Text] [Related]
7. Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis.
Lembo A; Camilleri M; McCallum R; Sastre R; Breton C; Spence S; White J; Currie M; Gottesdiener K; Stoner E;
Gastroenterology; 2016 Jul; 151(1):87-96.e6. PubMed ID: 27055601
[TBL] [Abstract][Full Text] [Related]
8. Randomized clinical trial: a controlled pilot trial of the 5-HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis.
Tack J; Rotondo A; Meulemans A; Thielemans L; Cools M
Neurogastroenterol Motil; 2016 Apr; 28(4):487-97. PubMed ID: 27010235
[TBL] [Abstract][Full Text] [Related]
9. Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study.
McCallum RW; Cynshi O;
Aliment Pharmacol Ther; 2007 Oct; 26(8):1121-30. PubMed ID: 17894654
[TBL] [Abstract][Full Text] [Related]
10. Effects of fedotozine on gastric emptying and upper gastrointestinal symptoms in diabetic gastroparesis.
Jones KL; Wishart JM; Berry MK; Abitbol JL; Horowitz M
Aliment Pharmacol Ther; 2000 Jul; 14(7):937-43. PubMed ID: 10886051
[TBL] [Abstract][Full Text] [Related]
11. Repeat polymorphisms in the Homo sapiens heme oxygenase-1 gene in diabetic and idiopathic gastroparesis.
Gibbons SJ; Grover M; Choi KM; Wadhwa A; Zubair A; Wilson LA; Wu Y; Abell TL; Hasler WL; Koch KL; McCallum RW; Nguyen LAB; Parkman HP; Sarosiek I; Snape WJ; Tonascia J; Hamilton FA; Pasricha PJ; Farrugia G
PLoS One; 2017; 12(11):e0187772. PubMed ID: 29161307
[TBL] [Abstract][Full Text] [Related]
12. A single-blinded, randomized pilot study evaluating effects of electroacupuncture in diabetic patients with symptoms suggestive of gastroparesis.
Wang CP; Kao CH; Chen WK; Lo WY; Hsieh CL
J Altern Complement Med; 2008 Sep; 14(7):833-9. PubMed ID: 18721079
[TBL] [Abstract][Full Text] [Related]
13. Effect of the motilin agonist KC 11458 on gastric emptying in diabetic gastroparesis.
Russo A; Stevens JE; Giles N; Krause G; O'Donovan DG; Horowitz M; Jones KL
Aliment Pharmacol Ther; 2004 Aug; 20(3):333-8. PubMed ID: 15274670
[TBL] [Abstract][Full Text] [Related]
14. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study.
Murray CD; Martin NM; Patterson M; Taylor SA; Ghatei MA; Kamm MA; Johnston C; Bloom SR; Emmanuel AV
Gut; 2005 Dec; 54(12):1693-8. PubMed ID: 16085693
[TBL] [Abstract][Full Text] [Related]
15. A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis.
Ejskjaer N; Wo JM; Esfandyari T; Mazen Jamal M; Dimcevski G; Tarnow L; Malik RA; Hellström PM; Mondou E; Quinn J; Rousseau F; McCallum RW
Neurogastroenterol Motil; 2013 Feb; 25(2):e140-50. PubMed ID: 23279217
[TBL] [Abstract][Full Text] [Related]
16. Velusetrag accelerates gastric emptying in subjects with gastroparesis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 study.
Kuo B; Barnes CN; Nguyen DD; Shaywitz D; Grimaldi M; Renzulli C; Canafax D; Parkman HP
Aliment Pharmacol Ther; 2021 May; 53(10):1090-1097. PubMed ID: 33811761
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled, phase 2b study of the efficacy and safety of velusetrag in subjects with diabetic or idiopathic gastroparesis.
Abell TL; Kuo B; Esfandyari T; Pfeifer ND; Grimaldi M; Renzulli C; Tacchi R; Zhou K; Barnes CN; Nguyen DD; Nguyen L; Talley NJ; McCallum R
Neurogastroenterol Motil; 2023 Apr; 35(4):e14523. PubMed ID: 36624727
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 10 Restores Gastric Emptying, Electrical Activity, and Interstitial Cells of Cajal Networks in Diabetic Mice.
Choi KM; Gibbons SJ; Sha L; Beyder A; Verhulst PJ; Cipriani G; Phillips JE; Bauer AJ; Ordog T; Camp JJ; Ge X; Bharucha AE; Linden DR; Szurszewski JH; Kashyap PC; Farrugia G
Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):454-467. PubMed ID: 27795979
[TBL] [Abstract][Full Text] [Related]
19. Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis.
McCallum RW; Lembo A; Esfandyari T; Bhandari BR; Ejskjaer N; Cosentino C; Helton N; Mondou E; Quinn J; Rousseau F;
Neurogastroenterol Motil; 2013 Nov; 25(11):e705-17. PubMed ID: 23848826
[TBL] [Abstract][Full Text] [Related]
20. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus.
Lacy BE; Crowell MD; Schettler-Duncan A; Mathis C; Pasricha PJ
Diabetes Care; 2004 Oct; 27(10):2341-7. PubMed ID: 15451898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
